RCUS
Rosen Terry J, RCUS's CEO, spent $128.7K of their own money on 15,770 shares at $8, growing their stake 1%.
+$128.7K
15,770 sh @ $8
RCUS
Arcus Biosciences, Inc.
SEC CIK 1724521
$23.80
+13.4% · 90 days
90-day buys
$0
0 open-market
90-day sells
$265K
2 open-market
Net insider flow
−$265K
Net selling
Filings shown
77
Most recent
Advertisement
At a glance
Over the last 90 days, insiders at RCUS have sold a net $265K of stock (0 open-market buys vs 2 sells).
Largest recent trade: Jaen Juan C. sold $2.05M of RCUS, trimming their stake 8%.
Most active filer: Rosen Terry J, with 42 transactions among the recent filings shown.
Insider transaction history
Form 4 filings for RCUS, newest firstRCUS
Rosen Terry J, RCUS's CEO, spent $164.8K of their own money on 10,650 shares at $15.
+$164.8K
10,650 sh @ $15
RCUS
Rosen Terry J, RCUS's CEO, spent $103.6K of their own money on 7,157 shares at $14.
+$103.6K
7,157 sh @ $14
RCUS
Rosen Terry J, RCUS's CEO, spent $11.9K of their own money on 800 shares at $15.
+$11.9K
800 sh @ $15
RCUS
Rosen Terry J, RCUS's CEO, spent $66.4K of their own money on 4,954 shares at $13.
+$66.4K
4,954 sh @ $13
Advertisement
RCUS
Rosen Terry J, RCUS's CEO, spent $28.8K of their own money on 2,133 shares at $14.
+$28.8K
2,133 sh @ $14
RCUS
Rosen Terry J, RCUS's CEO, spent $29.8K of their own money on 2,202 shares at $14.
+$29.8K
2,202 sh @ $14
RCUS
Rosen Terry J, RCUS's CEO, spent $36.8K of their own money on 2,790 shares at $13.
+$36.8K
2,790 sh @ $13
RCUS
Rosen Terry J, RCUS's CEO, spent $17.2K of their own money on 1,301 shares at $13.
+$17.2K
1,301 sh @ $13
RCUS
Rosen Terry J, RCUS's CEO, spent $63.7K of their own money on 4,800 shares at $13.
+$63.7K
4,800 sh @ $13
RCUS
Rosen Terry J, RCUS's CEO, spent $115.6K of their own money on 8,932 shares at $13.
+$115.6K
8,932 sh @ $13
RCUS
Rosen Terry J, RCUS's CEO, spent $167.2K of their own money on 13,300 shares at $13.
+$167.2K
13,300 sh @ $13
RCUS
Rosen Terry J, RCUS's CEO, spent $76.2K of their own money on 6,169 shares at $12.
+$76.2K
6,169 sh @ $12
RCUS
Rosen Terry J, RCUS's CEO, spent $38.5K of their own money on 3,279 shares at $12.
+$38.5K
3,279 sh @ $12
RCUS
Rosen Terry J, RCUS's CEO, spent $30.5K of their own money on 2,550 shares at $12.
+$30.5K
2,550 sh @ $12
RCUS
Rosen Terry J, RCUS's CEO, spent $48.9K of their own money on 4,100 shares at $12.
+$48.9K
4,100 sh @ $12
RCUS
Rosen Terry J, RCUS's CEO, spent $1,000K of their own money on 66,666 shares at $15, growing their stake 2%.
+$1,000K
66,666 sh @ $15
Advertisement
About RCUS insider activity
This page tracks every recent Form 4 filed for Arcus Biosciences, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
How often is RCUS insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for Arcus Biosciences, Inc. usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.